Are copper peptides an effective hair loss treatment? 4/8/2020
Copper peptides are discussed as a potential alternative to minoxidil for treating hair loss. Users share interest and challenges in accessing copper peptides, with some mentioning specific products.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity Regrowth on 6 months Dutasteride + Update
User reports regrowth at temples and improved hairline density after 6 months of using 0.5 mg Dutasteride daily, topical minoxidil twice daily, and vitamins. Considering adding copper peptide but concerned about overdoing it; experiencing increased shedding on the crown.
community Holding out for a miracle drug
A 41-year-old male has been using a combination of treatments for hair regrowth, including finasteride, minoxidil, a laser cap, ketoconazole shampoo, and rosemary oil, with some progress noted. He is maintaining his current regimen in hopes of a future miracle drug while considering hair transplants and other treatments like dutasteride and copper peptides.
community What happened to that guy who’s been drinking topical minoxidil?!
A user tried various hair growth treatments, including drinking topical minoxidil, using oral minoxidil and finasteride, and applying GHK-Cu, growth hormone peptides, and liposomal sulforaphane. They experienced thicker hair, while others discussed the risks and benefits of these methods.
community I stopped taking Min and deeply regretted it.
Stopping Minoxidil caused significant hair loss, which was mostly regained after resuming 1mg Finasteride and 3mg oral Minoxidil. Consistent use of both treatments is essential for maintaining hair growth.
community My (26m) Progress on 0.5mg Fin and 5% Topical Min
A 26-year-old male shares his progress using 0.5mg finasteride and 5% topical minoxidil for hair loss, considering transitioning to 3mg oral minoxidil. He is also contemplating using a hair system to boost confidence while continuing treatment.
community Story time! The Great Unbalding (PP405)
PP405 is a promising new hair loss treatment that may reactivate dormant hair follicles without side effects. It could surpass traditional treatments like minoxidil and finasteride if successful in further trials.
Related Research
6 / 6 results
research Enhanced Hair Regrowth with Five Monthly Sessions of Minoxidil-Dutasteride-Copper Peptides Tattooing for Androgenetic Alopecia Assessed by Artificial Intelligence and Blinded Evaluators
Five monthly sessions of minoxidil-dutasteride-copper peptide tattooing significantly improve hair regrowth in men with androgenetic alopecia.
research Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application
The researchers reported that a newly developed ionic liquid-based microemulsion significantly improved the local delivery of copper peptides in mice, enhancing hair growth-related factor activation while offering a safer, non-invasive alternative to existing treatments for hair loss.
research Chemical agents and peptides affect hair growth
This study found that topical minoxidil and diazoxide induced significant hair regrowth in bald macaques, while a steroid 5 alpha-reductase inhibitor prevented baldness in preadolescent macaques.
research Combined Regenerative Technique: Tattoo Machine–Assisted Drug Delivery for Androgenetic Alopecia
This study reports that a novel multimodal approach, combining tattoo machine–assisted drug delivery of hair loss treatments with oral and topical medications, may enhance hair density and thickness in androgenetic alopecia patients, though larger controlled studies are needed to confirm these early findings.
research Medical Management Options for Hair Loss
This review discusses both conventional and new pharmaceutical treatments for hair loss, as well as various natural and herbal remedies, but reports no new clinical results.
research Medical Hair Restoration Brings REVVup to HairLossSpecialists
This article introduces REVVup Hair Therapy as an alternative to surgery for early-stage hair loss but reports no new clinical findings.